Legal Proceedings
−Removed: We are currently a party to an action initiated by Merus N.V.
−Removed: (Merus) in the District of Delaware alleging that our manufacture, use, offer for sale, sale, and/or importation of common light chain antibodies and heterodimeric antibodies
−Removed: infringes certain claims of three Merus patents.
−Removed: Merus filed its complaint against us on August 5, 2024.
−Removed: Merus asserted claims of U.S.
−Removed: 9,944,695, 9,358,286 and 11,926,859 (collectively, the Asserted Patents).
−Removed: Merus seeks a judgment of patent infringement, an order enjoining us from infringing the Asserted Patents, a damages award (together with interest), a declaration of willful infringement, and a finding that this case is exceptional.
−Removed: On October 10, 2024, we filed a motion to dismiss the Merus complaint with prejudice under Rule 12(b)(6), in which we argued that all of the activities accused of infringement are covered by the 35 U.S.C.§ 271(e)(1) safe harbor.
−Removed: Merus filed its response to our motion on October 31, 2024, and we replied to Merus’ response on November 14, 2024.
−Removed: Both Merus and we requested a hearing for the motion to dismiss.
−Removed: On February 11, 2025, we filed for inter partes review of Merus’ U.S.
−Removed: 9,358,286 and 11,926,859 before the U.S.
−Removed: Patent and Trademark Appeal Board seeking a finding that certain claims of those patents are unpatentable.
−Removed: We believe we have strong defenses to Merus’ claims, including defenses of invalidity and/or non-infringement, but there is no guarantee that we will prevail.
+Added: Legal Proceedings are set forth in the Company’s financial statement schedules in Part II, Item 8 of this Annual Report on Form 10-K and are incorporated herein by reference.
+Added: See Note 7 - Commitments and Contingencies of Notes to Consolidated Financial Statements of Part II, “Item 8.
+Added: Financial Statements and Schedules.”
Mine Safety Disclosures
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.